Marcus Vinícius Oliveira Barros de Alencar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Marcus Vinícius Oliveira Barros de Alencar has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre de Barros Falcão Ferraz
Department of Industrial Pharmacy, Federal University of Santa Maria, Santa Maria 97105-900, RS, Brazil
2 shared publications - Muhammad Torequl Islam
Department of Pharmacy Gopalganj Science and Technology University Gopalganj Bangladesh
2 shared publications Alexandre Araujo de Souza
1 shared publicationAna Amélia de Carvalho Melo Cavalcante
Postgraduate Program in Biotechnology (RENORBIO), Federal University of Piauí, Teresina, Piauí, Brazil; Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, Teresina, Piauí, Brazil
1 shared publication- Ana Amélia de Carvalho Melo Cavalcante
Postgraduate Program in Biotechnology (RENORBIO), Federal University of Piauí, Teresina, Brazil
1 shared publication - Ana Amélia de Carvalho Melo-Cavalcante
Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Piauí, Campus Ministro Petrônio Portela, Bairro Ininga, Teresina, Piauí, CEP - 64049-550, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108643
Antioxidant, anti-inflammatory and cytotoxic/antitumoral bioactives from the phylum Basidiomycota and their possible mechanisms of action
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108643
Open AccessAntioxidant, anti-inflammatory and cytotoxic/antitumoral bioactives from the phylum Basidiomycota and their possible mechanisms of action
- 1 December 2018
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 227, 191-197
Mutagenic, antioxidant and wound healing properties of Aloe vera
- 1 December 2018
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 227, 191-197
Mutagenic, antioxidant and wound healing properties of Aloe vera
- Open Access
- 10 January 2016
- Published by Academic Journals in Journal of Medicinal Plants Research
- Vol. 10 (2) , 18-28
Toxicogenetic profile of rats treated with aqueous extract from Morinda citrifolia fruits
Morinda citrifolia ((Family: Rubiaceae)) is extensively used in traditional medicine due to its anti-inflammatory, antimicrobial, antitumoral, and anti-hypertensive activities. However, there is no substantial data about hepatotoxic and toxicogenetic effects. This study evaluated biochemical changes and hepatotoxic, genotoxic, and mutagenic effects of aqueous extract of the fruit of M. citrifolia (AEMC) in liver, bone marrow, and peripheral blood cells. Animals (Rattus novergicus, 5 males and 5 females) were divided into negative control, positive control (Cyclophosphamide 25 mg/kg), and AEMC (2.5, 5, and 10 mg/kg, by gavage). AEMC induced increase of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP), especially at 10 mg/kg in female (174.8 ± 50.7, 221.4 ± 24.6, and 174.7 ± 14.3 U/L) and male (156.5 ± 21.6, 183.7 ± 21.5, and 147.3 ± 17.8 U/L) (p<0.05). Histological analysis of livers showed inflammatory cell infiltration, nuclear fragmentation, microvacuolization, cellular swelling, points of inflammatoy necrosis, and discrete microvesicular steatosis. DNA damage in hepatocytes was found in both genders, mainly at 10 mg/kg (Frequency of Damage: 78.1 ± 4.5 and 70.4 ± 7.3%; Index of Damage: 107.6 ± 14.2 and 136.0 ± 26.9 for male and female, respectively). Similar results were observed in bone marrow cells. The AEMC 5 and 10 mg/kg induced micronucleus formation (4.4 ± 0.8 and 7.8 ± 1.1; 7.4 ± 1.1 and 9.6 ± 1.4 for peripheral blood and bone marrow cells, respectively) (p<0.05). These findings suggest clastogenic and/or aneugenic effects and genetic instability activated by AEMC, indicating precaution regarding the consumption of formulations or folk preparations based on this plant. Key words: Hepatotoxicity, genotoxicity, mutagenicity, Morinda citrifolia, noni.
- 10 January 2016
- Published by Academic Journals in Journal of Medicinal Plants Research
- Vol. 10 (2) , 18-28
Open AccessToxicogenetic profile of rats treated with aqueous extract from Morinda citrifolia fruits
Morinda citrifolia ((Family: Rubiaceae)) is extensively used in traditional medicine due to its anti-inflammatory, antimicrobial, antitumoral, and anti-hypertensive activities. However, there is no substantial data about hepatotoxic and toxicogenetic effects. This study evaluated biochemical changes and hepatotoxic, genotoxic, and mutagenic effects of aqueous extract of the fruit of M. citrifolia (AEMC) in liver, bone marrow, and peripheral blood cells. Animals (Rattus novergicus, 5 males and 5 females) were divided into negative control, positive control (Cyclophosphamide 25 mg/kg), and AEMC (2.5, 5, and 10 mg/kg, by gavage). AEMC induced increase of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP), especially at 10 mg/kg in female (174.8 ± 50.7, 221.4 ± 24.6, and 174.7 ± 14.3 U/L) and male (156.5 ± 21.6, 183.7 ± 21.5, and 147.3 ± 17.8 U/L) (p<0.05). Histological analysis of livers showed inflammatory cell infiltration, nuclear fragmentation, microvacuolization, cellular swelling, points of inflammatoy necrosis, and discrete microvesicular steatosis. DNA damage in hepatocytes was found in both genders, mainly at 10 mg/kg (Frequency of Damage: 78.1 ± 4.5 and 70.4 ± 7.3%; Index of Damage: 107.6 ± 14.2 and 136.0 ± 26.9 for male and female, respectively). Similar results were observed in bone marrow cells. The AEMC 5 and 10 mg/kg induced micronucleus formation (4.4 ± 0.8 and 7.8 ± 1.1; 7.4 ± 1.1 and 9.6 ± 1.4 for peripheral blood and bone marrow cells, respectively) (p<0.05). These findings suggest clastogenic and/or aneugenic effects and genetic instability activated by AEMC, indicating precaution regarding the consumption of formulations or folk preparations based on this plant. Key words: Hepatotoxicity, genotoxicity, mutagenicity, Morinda citrifolia, noni.
- Open Access
- 10 January 2016
- Published by Sciencedomain International in British Journal of Pharmaceutical Research
- Vol. 10 (3) , 1-6
Toxic Effects of Aqueous Extract of Plectranthus amboinicus (Lour) Spreng on Allium cepa
Aims: Plectranthus amboinicus (Lour) Spreng. belonging to the Lamiaceae family being extensively used in folk medicine for its anti-inflammatory effects, nonetheless, there is a lack of more substantial data on the toxicogenetic effects of this preparations. This study aimed to evaluate possible cytotoxic effects of aqueous extract of leaves of Plectranthus amboinicus on Allium cepa assay.
- 10 January 2016
- Published by Sciencedomain International in British Journal of Pharmaceutical Research
- Vol. 10 (3) , 1-6
Open AccessToxic Effects of Aqueous Extract of Plectranthus amboinicus (Lour) Spreng on Allium cepa
Aims: Plectranthus amboinicus (Lour) Spreng. belonging to the Lamiaceae family being extensively used in folk medicine for its anti-inflammatory effects, nonetheless, there is a lack of more substantial data on the toxicogenetic effects of this preparations. This study aimed to evaluate possible cytotoxic effects of aqueous extract of leaves of Plectranthus amboinicus on Allium cepa assay.
- Open Access
- 8 February 2014
- Published by Academic Journals in African Journal of Pharmacy and Pharmacology
- Vol. 7 (30) , 136-147
Evaluation of antioxidant capacity of the aqueous extract of Cynara scolymus L. (Asteraceae) in vitro and in Saccharomyces cerevisiae
- 8 February 2014
- Published by Academic Journals in African Journal of Pharmacy and Pharmacology
- Vol. 7 (30) , 136-147
Open AccessEvaluation of antioxidant capacity of the aqueous extract of Cynara scolymus L. (Asteraceae) in vitro and in Saccharomyces cerevisiae